medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2017, Número 1

<< Anterior Siguiente >>

Rev Invest Clin 2017; 69 (1)


Clinical and Demographic Predictors of Conversion to Dementia in Mexican Elderly with Mild Cognitive Impairment

Aguilar-Navarro SG, Mimenza-Alvarado AJ, Ávila-Funes JA, Juárez-Cedillo T, Bernal-López C, Hernández-Favela CG

Idioma: Ingles.
Referencias bibliográficas: 35
Paginas: 33-39
Archivo PDF: 176.73 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999; 56:303-8.

  2. Jak AJ, Preis SR, Beiser AS, et al. Neuropsychological criteria for mild cognitive impairment and dementia risk in the Framingham Heart Study. J Int Neuropsychol Soc. 2016;22:937-943.

  3. Petersen RC, Rosebud O, Roberts RO, et al. Mild cognitive impairment: ten years later. Arch Neurol. 2009;66:1447-55.

  4. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2014;9:63-75.

  5. Roberts R, Knopman DS. Classification and epidemiology of mild cognitive impairment. Clin Ger Med. 2013;29:753-72.

  6. Koepsell TD, Monsell SE. Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis. Neurology. 2012;79:1591-8.

  7. Campbell NL, Unverzagt F, LaMantia MA, Khan BA, Boustani MA. Risk factors for the progression of mild cognitive impairment to dementia. Clin Ger Med. 2013;29:873-93.

  8. Prince M, Albanese E, Guerchet M, Prina M. World Alzheimer’s Report 2014: Dementia and risk reduction. An analysis of protective and modifiable factors. Public health priority. [e-journal] 2014. Available at: www.alz.co.uk/research/ [Accessed November 10, 2014].

  9. Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State” a practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res. 1975;12:189-98.

  10. Morris J. The clinical dementia rating (CDR): Current version and scoring rules. Neurology. 1993;43:2412-14.

  11. Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychological function. JAMA. 1963;185:914-19.

  12. L awton MP, Brody EM. Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179-86.

  13. Petersen RC. Clinical practice. Mild cognitive impairment. N Engl J Med. 2011;364:2227-2234.

  14. Dubois B, Touchon J, Portet F, Ousset PJ, Vellas B, Michel B. The 5 words’: A simple and sensitive test for the diagnosis of Alzheimer’s disease. Presse Med. 2002;31:1696-9.

  15. Canning SJ, Leach L, Stuss D, Ngo L, Black SE. Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementia. Neurology. 2004;62:556-62.

  16. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: A frontal assessment battery at bedside. Neurology. 2000;55:1621-6.

  17. Shulman KI. Clock-drawing: Is it the ideal cognitive screening test? Int J Geriatr Psychiatry. 2000;15:548-61.

  18. A merican Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revision (DSM-IV-TR) Barcelona: Masson. 2002.

  19. Pohjasvaara T, Mantyla R, Ylikoski R, Kaste M, Erkinjuntti T. Comparison of different clinical criteria (DSM-III, ADDTC, ICD- 10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke- Association Internationale pour la Recherche et I’ Enseignement en Neurosciences. Stroke. 2000;31:2952-7.

  20. N eary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546-54.

  21. McKeith I, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863-72.

  22. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDSAIREN International Workshop. Neurology. 1993;43:250-60.

  23. O ´Connor PG, Schottenfeld RS. Patients with alcohol problems. N Engl J Med. 1998;338:592-602.

  24. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiat Res. 1982;17:34-7.

  25. Katz Mj, Lipton RB, Hall CB, et al. Age and sex specific prevalence and incidence of mild cognitive impairment, dementia and Alzheimer’s dementia in blacks and whites: A report from The Einstein Aging Study. Alzheimer Dis Assoc Disord. 2012;26:335-43.

  26. Vos SJ, Xiong C, Visser PJ, et al. Preclinical Alzheimer’s disease and its outcome: a longitudinal cohort study. Lancet Neurol. 2013;12:957-65.

  27. Solfrizzi V, Panza F, Colacicco AM, et al. Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology. 2004;63:1882-91.

  28. Mejia-Aranjo S, Gutiérrez-Robledo LM. Prevalence and incidence rates of dementia and cognitive impairment no dementia in the Mexican population: data from the Mexican Health and Aging Study. J Aging Health. 2011;23:1050-74.

  29. Sosa AL, Albanese E, Stephan BC, et al. Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China and India: A 10/66 Population-Based Study. PLoS Med. 2012;9: e1001170.

  30. Cooper C, Sommerlad A, Lyketsos CG, et al. Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. Am J Psychiatry. 2015;172:323-34.

  31. Ding D, Zhao O, Guo Q, et al. Progression and predictors of mild cognitive impairment in Chinese elderly: A prospective follow-up in the Shanghai Aging Study. Alzheimers Dement (Amst). 2016; 4:28-36.

  32. Inselberg R, Massarwa M, Schechtman E, Strugatsky R, Farrer LA, Friedland RP. Estimating the risk for conversion from mild cognitive impairment to Alzheimer’s disease in an elderly Arab community. J Alzheimers Dis. 2015;45:865-71.

  33. L i J, Wanj YJ, Zhang M, et al. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology. 2011;76:1485-91.

  34. Bejot Y, Aboa-Eboulé C, Durier J, et al. Prevalence of early dementia after first-ever stroke: a 24-year population based study. Stroke. 2011;42:607-12.

  35. Khedr EM, Hamed SA, El-Shereef HK, et al. Cognitive impairment after cerebrovascular stroke: relationship to vascular risk factors. Neuropsychiatr Dis Treat. 2009;5:103-16.




2020     |     www.medigraphic.com